96997-17-0

Upstream product

• 107256-81-5 α-[2-[bis(1-methylethyl)amino]ethyl]-α-phenyl-2-piperidineacetamide 
• 74427-45-5 disopyramide 
• 917-64-6 methyl magnesium iodide 
• 91256-98-3 (4R,4aR)-4-(2-Diisopropylamino-ethyl)-4-phenyl-4,4a,5,6,7,8-hexahydro-pyrido[1,2-c]pyrimidin-3-one 

Relevant academic research and scientific papers

Substituted 5-phenyl-5-(aminoalkyl)-1,3-diazabicyclo[4.4.0]decan-4-ones and 5-phenyl-5-(aminoalkyl)-1,3-diazabicyclo[4.4.0]dec-2-en-4-ones

This invention relates to 5-(substituted phenyl)-5-[(substituted amino)alkyl]-1,3-diazabicyclo[4.4.0]decan-4-ones and 5-(substituted phenyl)-5-[(substituted amino)-alkyl]-1,3-diazabicyclo[4.4.0]dec-2-en-4-ones that are useful as antiarrhythmic agents.

Synthesis and Structure-Activity Relationships of a New Series of Antiarrhytmic Agents: 4,4-Disubstituted Hexahydro-3H-pyridopyrimidin-3-ones and Related Compounds

A series of 4,4-disubstituted tetrahydro- and 4,4-disubstituted hexahydro-3H-pyridopyrimidin-3-ones (4 and 5, respectively) were prepared from 2-aryl-2-(2-piperidinyl)-4-butanamides (2).Individual racemates of the piper